Resta O, Pannacciulli N, Di Gioia G, Stefàno A, Barbaro M P Foschino, De Pergola G
Respiratory Diseases, Department of Clinical Methodology and Medical-Surgical Technologies, University of Bari, School of Medicine, Bari, Italy.
Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):248-53. doi: 10.1016/s0939-4753(04)80051-6.
To evaluate the prevalence of previously unknown hypothyroidism in adult male and female patients with a wide range of body mass index (BMI) values, referred to a Sleep Clinic because of sleep disordered breathing (SDB).
Serum concentrations of thyroid stimulating hormone (TSH) and free thyroxin (fT4), as well as forced vital capacity (FVC), PaO2, PaCO2, the Epworth sleepiness scale (ESS), respiratory disturbance index (RDI), loud snoring, and the percentage of total sleep time (TST) with <90% oxyhemoglobin saturation (TST(saO2<90%)) were measured in 78 overweight and obese adult subjects with no previous diagnosis of hypothyroidism (age: 18-72 years). The prevalence of previously undiagnosed subclinical hypothyroidism in the population as a whole was 11.5%. BMI, TSH and ESS were significantly higher in the hypothyroid than the euthyroid subjects, but there was no significant between-group difference in RDI, TST(saO2<90%) or the other investigated variables, including the prevalence of obstructive sleep apnea (OSA). Among the hypothyroid individuals, BMI, neck circumference, ESS, RDI and TST(Sao2<90%) were significantly higher in those with than in those without OSA. Furthermore, there was a clear trend towards a lower FVC% and higher snoring score in the OSA patients.
Our results demonstrate a higher prevalence of hypothyroidism than that commonly reported in overweight and obese individuals referred to a Sleep Clinic for polysomnography because of SDB, thus suggesting that thyroid function should be evaluated in all obese patients suffering from SDB despite economic concerns.
评估因睡眠呼吸紊乱(SDB)而转诊至睡眠诊所的、具有广泛体重指数(BMI)值的成年男性和女性患者中先前未知的甲状腺功能减退症的患病率。
对78名既往未诊断为甲状腺功能减退症的超重和肥胖成年受试者(年龄:18 - 72岁)测量血清促甲状腺激素(TSH)和游离甲状腺素(fT4)浓度,以及用力肺活量(FVC)、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、爱泼华嗜睡量表(ESS)、呼吸紊乱指数(RDI)、大声打鼾情况以及氧合血红蛋白饱和度<90%的总睡眠时间百分比(TST(saO2<90%))。总体人群中先前未诊断的亚临床甲状腺功能减退症的患病率为11.5%。甲状腺功能减退患者的BMI、TSH和ESS显著高于甲状腺功能正常的受试者,但两组之间在RDI、TST(saO2<90%)或其他研究变量(包括阻塞性睡眠呼吸暂停(OSA)的患病率)方面无显著差异。在甲状腺功能减退个体中,患有OSA的个体的BMI、颈围、ESS、RDI和TST(Sao2<90%)显著高于未患OSA的个体。此外,OSA患者的FVC%有降低趋势,打鼾评分有升高趋势。
我们的结果表明,因SDB而转诊至睡眠诊所进行多导睡眠图检查的超重和肥胖个体中,甲状腺功能减退症的患病率高于通常报道的水平,因此表明尽管存在经济顾虑,但对于所有患有SDB的肥胖患者都应评估甲状腺功能。